Kimberly-Clark (KMB) has a market cap of $40.8 billion. It fell 4.7% to close at $113.91 per share on October 24, 2016. The stock’s weekly, monthly, and year-to-date (or YTD) price movements were -5.6%, -10.1%, and -8.6%, respectively, on the same day. KMB is trading 7.1% below its 20-day moving average, 8.6% below its 50-day moving average, and 11.1% below its 200-day moving average.
Related ETF and peers
The PowerShares DWA Consumer Staples Momentum Portfolio (PSL) invests 3.1% of its holdings in Kimberly-Clark. The ETF tracks an index of US consumer cyclical firms selected and weighted by price momentum. The YTD price movement of PSL was -0.33% on October 24.
The market caps of Kimberly-Clark’s competitors are as follows:
Performance of KMB in 3Q16
Kimberly-Clark reported 3Q16 net sales of $4.6 billion, a fall of 2.8% compared to net sales of $4.7 billion in 3Q15 due to the impact of foreign currency exchange rates. Sales from the personal care, consumer tissue, and K-C professional segments fell 1.9%, 3.7%, and 2.9%, respectively, in 3Q16 compared to 3Q15. The company’s gross profit margin and operating margin rose by 70 basis points and 170 basis points, respectively, in 3Q16 compared to the prior-year period.
The company’s net income and EPS (earnings per share) rose to $550.0 million and $1.52, respectively, in 3Q16 compared to $517.0 million and $1.41, respectively, in 3Q15. It reported adjusted EPS of $1.52 in 3Q16, a rise of 0.66% compared to 3Q15.
KMB’s cash and cash equivalents rose 42.8%, and its inventories fell 9.1% in 3Q16 compared to 4Q15. Its current ratio rose to 0.92x in 3Q16 compared to 0.85x in 4Q15.
During 3Q16, the company repurchased 1.7 million shares worth $225 million.
The company has made the following projections for fiscal 2016:
- It expects the effect of negative foreign currency translation on net sales and organic profit of 4% and 3%, respectively.
- It expects organic sales growth of 2%.
- It expects adjusted EPS in the range of $5.95 to $6.05.
- It expects share repurchases of $750 million.
Now we’ll discuss Blue Buffalo Pet Products (BUFF).